BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · IEX Real-Time Price · USD
9.24
+0.16 (1.76%)
At close: Jun 24, 2022 4:00 PM
9.20
-0.04 (-0.43%)
After-hours:
Jun 24, 2022 7:56 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
|
Revenue
|
69.72 | 8.25 | 40.56 | 0 | 0 |
|
Revenue Growth (YoY)
|
745.14% | -79.66% | - | - | - |
|
Cost of Revenue
|
3.11 | 0 | 2.5 | 0 | 0 |
|
Gross Profit
|
66.6 | 8.25 | 38.06 | 0 | 0 |
|
Selling, General & Admin
|
192.21 | 145.68 | 94.35 | 43.59 | 13.3 |
|
Research & Development
|
451.02 | 337.05 | 209.95 | 140.07 | 30.56 |
|
Operating Expenses
|
643.23 | 482.73 | 304.3 | 183.66 | 43.86 |
|
Operating Income
|
-576.63 | -474.48 | -266.24 | -183.66 | -43.86 |
|
Interest Expense / Income
|
46.78 | 36.66 | 8.77 | 2.55 | 0.01 |
|
Other Expense / Income
|
-60.87 | -62.41 | -14.42 | -55.46 | -13.31 |
|
Pretax Income
|
-562.54 | -448.72 | -260.59 | -130.75 | -30.57 |
|
Net Income
|
-562.54 | -448.72 | -260.59 | -130.75 | -30.57 |
|
Net Income Common
|
-562.54 | -448.72 | -260.59 | -130.75 | -30.57 |
|
Shares Outstanding (Basic)
|
144 | 118 | 105 | 62 | 31 |
|
Shares Outstanding (Diluted)
|
144 | 118 | 105 | 62 | 31 |
|
Shares Change
|
22.34% | 12.27% | 70.15% | 101.86% | - |
|
EPS (Basic)
|
-3.90 | -3.80 | -2.48 | -2.12 | -1.00 |
|
EPS (Diluted)
|
-3.90 | -3.80 | -2.48 | -2.12 | -1.00 |
|
Free Cash Flow Per Share
|
-3.54 | -3.45 | -2.44 | -2.25 | -1.34 |
|
Gross Margin
|
95.53% | 100.00% | 93.84% | - | - |
|
Operating Margin
|
-827.12% | -5751.99% | -656.41% | - | - |
|
Profit Margin
|
-806.90% | -5439.74% | -642.47% | - | - |
|
Free Cash Flow Margin
|
-733.23% | -4936.74% | -631.72% | - | - |
|
EBITDA
|
-504.31 | -407.53 | -250.96 | -128.2 | -30.55 |
|
EBITDA Margin
|
-723.37% | -4940.30% | -618.75% | - | - |
|
Depreciation & Amortization
|
11.45 | 4.54 | 0.86 | 0 | 0 |
|
EBIT
|
-515.76 | -412.07 | -251.82 | -128.2 | -30.55 |
|
EBIT Margin
|
-739.80% | -4995.38% | -620.86% | - | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).